当前位置: X-MOL 学术Trop. Dr. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Assessment of symptomatic response to intravesical alkalinized lidocaine, bupivacaine, heparin and steroids in patients with bladder pain syndrome
Tropical Doctor ( IF 0.6 ) Pub Date : 2024-03-18 , DOI: 10.1177/00494755241236993
Ravikant Mahant 1 , Fanindra Singh Solanki 2 , Chandan Tiwari 1 , Ankush Lokhande 3 , Deepti B Sharma 4 , Dhananjaya Sharma 5
Affiliation  

Bladder Pain Syndrome (BPS) is a puzzling and complicated disorder. 12 such patients, with a mean age 48.3 years, were treated with weekly intravesical instillation of admixture of alkalinized lidocaine, bupivacaine, heparin and steroids for six weeks. Evaluating the benefits of this therapy, patients experienced 82.2% & 90.9% relief at 3rd & 6th week of instillation. After completion of six cycles of therapy, patients experienced 68.7% & 65.3% relief at 3rd & 6th month follow up, concluding the early and long term relief of BPS.

中文翻译:

膀胱疼痛综合征患者对膀胱内碱化利多卡因、布比卡因、肝素和类固醇的症状反应评估

膀胱疼痛综合症(BPS)是一种令人费解且复杂的疾病。 12 名平均年龄 48.3 岁的患者接受了每周膀胱内滴注碱化利多卡因、布比卡因、肝素和类固醇混合物的治疗,持续六周。评估这种疗法的益处,患者在 3 岁时症状缓解分别为 82.2% 和 90.9%RD&6th滴注一周。完成六个治疗周期后,患者在第 3 个周期的症状缓解分别为 68.7% 和 65.3%RD&6th一个月的随访,结束 BPS 的早期和长期缓解。
更新日期:2024-03-18
down
wechat
bug